Janus Living (JAN) Has Analysts’ Attention. Here’s Why They Like It Farooq Mon, November 9, 2026 at 1:52 PM EST 4 min read JAN +0.09% ^GSPC +2.29% We just published a list of the 10 Best All-Time High Stocks to Buy According to Wall Street and Janus Living (NYSE:JAN) ranked 8th on this list.
Wall Street's leadership changed hands over the past month. The technology and chip stocks that carried the market through most of 2026 lost ground, while healthcare, financials, real estate, utilities and consumer-focused stocks took over.
The scoreboard showed it in mid-October. Healthcare led gains among the S&P 500's 11 sectors and hit a record high, financials rose 1%, real estate climbed 1.7% and utilities added 1.2%, while technology slipped 0.3%. The S&P 500 value index gained 0.9% that day as its growth counterpart dipped 0.2%. Jim Baird, chief investment officer at Plante Moran Financial Advisors, tied the move to doubts about AI payoffs: "Investors are looking for other opportunities outside of tech, and healthcare is one of the beneficiaries of that."
The rotation sped up in November. On Monday, investors moved into consumer cyclical, financial services and consumer defensive stocks, and the main technology sector fund was down 2.4% by mid-afternoon. Last Thursday, the Philadelphia Semiconductor Index fell as much as 11%, its worst showing since March 2020, and the Nasdaq Composite slid into a correction, a drop of at least 10% from its record close in early October. The VIX, Wall Street's fear gauge, jumped more than 65% in a day. In short, money moved toward companies with steadier earnings and away from the most crowded trades.
Sameer Samana, senior global market strategist at Wells Fargo Investment Institute, said the pain was concentrated: "Anything related to AI is down more than anything not related to AI." Our ranking of stocks sitting near all-time highs that Wall Street favors looks at names that have held up through the swings.
Samana described the shift as a change of buyers. The first wave of AI investors chased growth, he said, while a newer group wants companies with healthy cash flow, and he noted that many AI stocks are still not cheap. Will Compernolle, a macro strategist at FHN Financial, said the selling in chipmakers was sending money into Treasuries, and that investors were also rotating from chipmakers into the biggest spenders on AI data centers.
We covered the group that led October's gains in our list of healthcare stocks that hedge funds favor. Not everyone reads the selloff as a verdict on the economy. Charlie McElligott, a cross-asset strategist at Nomura, said it reflected hedge funds locking in their 2026 gains rather than a worsening in fundamentals.
Janus Living made it to our list because it has an average upside potential of 8%. Janus Living's senior housing communities are fuller than they were a year ago, and residents are paying more per unit. Average occupancy rose by 300 basis points in the third quarter, which helped lift same-store adjusted net operating income by 25.9%. The company calls itself a pure-play senior housing real estate investment trust, so demand for those apartments drives nearly everything it earns. Fuller buildings and higher rents together are what push net operating income up faster than revenue.
It is spending to get bigger while conditions are strong. In the quarter it bought 33 communities for about $1.75 billion, funded in part by an August stock offering. More purchases have closed since quarter-end, and others are under binding agreements to close in the fourth quarter.
Management raised its full-year outlook for FFO as adjusted, a cash earnings measure used by real estate companies, to $0.97 to $0.99 per share, from $0.95 to $0.98. It also lifted its forecast for same-store growth in net operating income, which signals that leaders expect the gains in occupancy and pricing to carry into the final months of the year.
While we acknowledge the potential of JAN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Thermo Fisher (TMO) Is Turning Innovation Into Recurring Revenue. Can Margins Follow? and Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?
This article is originally published at Insider Monkey.
